FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3037989839> ?p ?o ?g. }

• W3037989839 endingPage "1233" @default.
• W3037989839 startingPage "1222" @default.
• W3037989839 abstract "Direct-acting antiviral treatments for chronic hepatitis C virus (HCV) infection are generally safe; however, understanding the safety profile of each regimen is essential for their continued use. Safety data were pooled from 12 clinical trials of elbasvir/grazoprevir (EBR/GZR) that enrolled adult participants with HCV infection. Pooled analyses are presented for participants receiving EBR/GZR for 12 weeks and those receiving EBR/GZR plus ribavirin (RBV) for 16-18 weeks. Safety data are also presented for participants with comorbidities receiving EBR/GZR for 12 weeks in individual clinical trials (chronic kidney disease [CKD] stage 4/5, inherited blood disorders [IBLD] or receiving opioid agonist therapy [OAT]). Among 1743 participants receiving EBR/GZR for 12 weeks, 1068 (61.3%) reported ≥1 adverse event (AE) and 491 had AEs (28.2%) considered drug-related. The most frequent AEs were headache (10.6%), fatigue (8.7%), nasopharyngitis (5.8%), nausea (5.1%) and diarrhoea (5.0%). Serious AEs were reported by 37 participants (2.1%), and 12 (0.7%) discontinued treatment due to an AE. In populations with CKD 4/5 or IBLD or receiving OAT, safety was similar in participants receiving EBR/GZR for 12 weeks and those receiving placebo. Some AEs occurred at higher frequencies in participants receiving RBV compared with those receiving EBR/GZR alone: fatigue (32.7% vs 8.7%); headache (21.6% vs 10.6%); and nausea (15.8% vs 5.1%). Safety was similar in participants with and those without cirrhosis. Grade 3/4 alanine aminotransferase elevations were reported in 0.7% participants. EBR/GZR is a safe treatment option for individuals with HCV genotype (GT) 1 or GT4 infections, even those with challenging comorbidities such as CKD or IBLD and those receiving OAT." @default.
• W3037989839 created "2020-07-02" @default.
• W3037989839 creator A5021954687 @default.
• W3037989839 creator A5029165106 @default.
• W3037989839 creator A5039066540 @default.
• W3037989839 creator A5050905161 @default.
• W3037989839 creator A5079795365 @default.
• W3037989839 creator A5080796048 @default.
• W3037989839 creator A5087935658 @default.
• W3037989839 creator A5089019494 @default.
• W3037989839 date "2020-08-10" @default.
• W3037989839 modified "2023-09-25" @default.
• W3037989839 title "Safety and tolerability of elbasvir/grazoprevir in chronic hepatitis C virus therapy: Integrated analysis from clinical trials" @default.
• W3037989839 cites W1621802947 @default.
• W3037989839 cites W1908153784 @default.
• W3037989839 cites W2094778224 @default.
• W3037989839 cites W2118684050 @default.
• W3037989839 cites W2161578383 @default.
• W3037989839 cites W2185218296 @default.
• W3037989839 cites W2292010270 @default.
• W3037989839 cites W2513962667 @default.
• W3037989839 cites W2518041763 @default.
• W3037989839 cites W2527946790 @default.
• W3037989839 cites W2552544908 @default.
• W3037989839 cites W2578013986 @default.
• W3037989839 cites W2593329923 @default.
• W3037989839 cites W2609473168 @default.
• W3037989839 cites W2769875106 @default.
• W3037989839 cites W2789565767 @default.
• W3037989839 cites W2796414261 @default.
• W3037989839 cites W2886130990 @default.
• W3037989839 cites W2897976761 @default.
• W3037989839 cites W2913784133 @default.
• W3037989839 cites W2938961534 @default.
• W3037989839 cites W2972981094 @default.
• W3037989839 doi "https://doi.org/10.1111/jvh.13357" @default.
• W3037989839 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32594612" @default.
• W3037989839 hasPublicationYear "2020" @default.
• W3037989839 type Work @default.
• W3037989839 sameAs 3037989839 @default.
• W3037989839 citedByCount "2" @default.
• W3037989839 countsByYear W30379898392021 @default.
• W3037989839 countsByYear W30379898392023 @default.
• W3037989839 crossrefType "journal-article" @default.
• W3037989839 hasAuthorship W3037989839A5021954687 @default.
• W3037989839 hasAuthorship W3037989839A5029165106 @default.
• W3037989839 hasAuthorship W3037989839A5039066540 @default.
• W3037989839 hasAuthorship W3037989839A5050905161 @default.
• W3037989839 hasAuthorship W3037989839A5079795365 @default.
• W3037989839 hasAuthorship W3037989839A5080796048 @default.
• W3037989839 hasAuthorship W3037989839A5087935658 @default.
• W3037989839 hasAuthorship W3037989839A5089019494 @default.
• W3037989839 hasConcept C126322002 @default.
• W3037989839 hasConcept C197934379 @default.
• W3037989839 hasConcept C203014093 @default.
• W3037989839 hasConcept C2522874641 @default.
• W3037989839 hasConcept C2776408679 @default.
• W3037989839 hasConcept C2778375690 @default.
• W3037989839 hasConcept C2780040827 @default.
• W3037989839 hasConcept C2780580376 @default.
• W3037989839 hasConcept C2781413609 @default.
• W3037989839 hasConcept C71924100 @default.
• W3037989839 hasConcept C90924648 @default.
• W3037989839 hasConceptScore W3037989839C126322002 @default.
• W3037989839 hasConceptScore W3037989839C197934379 @default.
• W3037989839 hasConceptScore W3037989839C203014093 @default.
• W3037989839 hasConceptScore W3037989839C2522874641 @default.
• W3037989839 hasConceptScore W3037989839C2776408679 @default.
• W3037989839 hasConceptScore W3037989839C2778375690 @default.
• W3037989839 hasConceptScore W3037989839C2780040827 @default.
• W3037989839 hasConceptScore W3037989839C2780580376 @default.
• W3037989839 hasConceptScore W3037989839C2781413609 @default.
• W3037989839 hasConceptScore W3037989839C71924100 @default.
• W3037989839 hasConceptScore W3037989839C90924648 @default.
• W3037989839 hasIssue "11" @default.
• W3037989839 hasLocation W30379898391 @default.
• W3037989839 hasLocation W30379898392 @default.
• W3037989839 hasOpenAccess W3037989839 @default.
• W3037989839 hasPrimaryLocation W30379898391 @default.
• W3037989839 hasRelatedWork W1973342136 @default.
• W3037989839 hasRelatedWork W1982049955 @default.
• W3037989839 hasRelatedWork W2002502340 @default.
• W3037989839 hasRelatedWork W2007986200 @default.
• W3037989839 hasRelatedWork W2022556905 @default.
• W3037989839 hasRelatedWork W2281121233 @default.
• W3037989839 hasRelatedWork W2393784267 @default.
• W3037989839 hasRelatedWork W2394317912 @default.
• W3037989839 hasRelatedWork W2768156108 @default.
• W3037989839 hasRelatedWork W4251165208 @default.
• W3037989839 hasVolume "27" @default.
• W3037989839 isParatext "false" @default.
• W3037989839 isRetracted "false" @default.
• W3037989839 magId "3037989839" @default.
• W3037989839 workType "article" @default.